These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22731783)

  • 21. Allosteric inhibition of the DNA-dependent ATPase activity of Escherichia coli DNA gyrase by a representative of a novel class of inhibitors.
    Shapiro AB; Andrews B
    Biochem Pharmacol; 2012 Oct; 84(7):900-4. PubMed ID: 22820247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the gyrase ATPase domain for tailoring newer anti-tubercular drugs: hit to lead optimization of a novel class of thiazole inhibitors.
    Jeankumar VU; Kotagiri S; Janupally R; Suryadevara P; Sridevi JP; Medishetti R; Kulkarni P; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2015 Feb; 23(3):588-601. PubMed ID: 25541204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the noviose.
    Lafitte D; Lamour V; Tsvetkov PO; Makarov AA; Klich M; Deprez P; Moras D; Briand C; Gilli R
    Biochemistry; 2002 Jun; 41(23):7217-23. PubMed ID: 12044152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein.
    Garrido SS; Scatigno AC; Trovatti E; Carvalho DC; Marchetto R
    J Pept Res; 2005 May; 65(5):502-11. PubMed ID: 15853944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
    Charifson PS; Grillot AL; Grossman TH; Parsons JD; Badia M; Bellon S; Deininger DD; Drumm JE; Gross CH; LeTiran A; Liao Y; Mani N; Nicolau DP; Perola E; Ronkin S; Shannon D; Swenson LL; Tang Q; Tessier PR; Tian SK; Trudeau M; Wang T; Wei Y; Zhang H; Stamos D
    J Med Chem; 2008 Sep; 51(17):5243-63. PubMed ID: 18690678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase.
    van Linden OP; Farenc C; Zoutman WH; Hameetman L; Wijtmans M; Leurs R; Tensen CP; Siegal G; de Esch IJ
    Eur J Med Chem; 2012 Jan; 47(1):493-500. PubMed ID: 22137457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new DNA gyrase inhibitor subclass of the cyclothialidine family based on a bicyclic dilactam-lactone scaffold. Synthesis and antibacterial properties.
    Angehrn P; Goetschi E; Gmuender H; Hebeisen P; Hennig M; Kuhn B; Luebbers T; Reindl P; Ricklin F; Schmitt-Hoffmann A
    J Med Chem; 2011 Apr; 54(7):2207-24. PubMed ID: 21388139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structures of kibdelomycin bound to Staphylococcus aureus GyrB and ParE showed a novel U-shaped binding mode.
    Lu J; Patel S; Sharma N; Soisson SM; Kishii R; Takei M; Fukuda Y; Lumb KJ; Singh SB
    ACS Chem Biol; 2014 Sep; 9(9):2023-31. PubMed ID: 24992706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action.
    Heddle JG; Barnard FM; Wentzell LM; Maxwell A
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1249-64. PubMed ID: 11097055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smaller is better for antibiotic discovery.
    Waldrop GL
    ACS Chem Biol; 2009 Jun; 4(6):397-9. PubMed ID: 19537754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATP Competitive DNA Gyrase B Inhibitors: Design, Synthesis, and Evaluation.
    Zidar N; Macut H; Tomašič T; Brvar M; Montalvão S; Tammela P; Solmajer T; Peterlin Mašič L; Ilaš J; Kikelj D
    J Med Chem; 2015 Aug; 58(15):6179-94. PubMed ID: 26126187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo design of novel DNA-gyrase inhibitors based on 2D molecular fingerprints.
    Huang Z; Lin K; You Q
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4166-71. PubMed ID: 23743285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological evaluation of novel Pseudomonas aeruginosa DNA gyrase B inhibitors.
    Jogula S; Krishna VS; Meda N; Balraju V; Sriram D
    Bioorg Chem; 2020 Jul; 100():103905. PubMed ID: 32388436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linker-switch approach towards new ATP binding site inhibitors of DNA gyrase B.
    Jukič M; Ilaš J; Brvar M; Kikelj D; Cesar J; Anderluh M
    Eur J Med Chem; 2017 Jan; 125():500-514. PubMed ID: 27689732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
    Angehrn P; Buchmann S; Funk C; Goetschi E; Gmuender H; Hebeisen P; Kostrewa D; Link H; Luebbers T; Masciadri R; Nielsen J; Reindl P; Ricklin F; Schmitt-Hoffmann A; Theil FP
    J Med Chem; 2004 Mar; 47(6):1487-513. PubMed ID: 14998336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antibacterial property of pyrrolopyrano quinolinones and pyrroloquinolines.
    Jayagobi M; Raghunathan R; Sainath S; Raghunathan M
    Eur J Med Chem; 2011 Jun; 46(6):2075-82. PubMed ID: 21444131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high-throughput fluorescence polarization assay for inhibitors of gyrase B.
    Glaser BT; Malerich JP; Duellman SJ; Fong J; Hutson C; Fine RM; Keblansky B; Tang MJ; Madrid PB
    J Biomol Screen; 2011 Feb; 16(2):230-8. PubMed ID: 21245469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free energies and entropies of water molecules at the inhibitor-protein interface of DNA gyrase.
    Yu H; Rick SW
    J Am Chem Soc; 2009 May; 131(18):6608-13. PubMed ID: 19374378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular modeling of Mycobacterium tuberculosis DNA gyrase and its molecular docking study with gatifloxacin inhibitors.
    da Cunha EE; Barbosa EF; Oliveira AA; Ramalho TC
    J Biomol Struct Dyn; 2010 Apr; 27(5):619-25. PubMed ID: 20085379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis.
    Minovski N; Perdih A; Novic M; Solmajer T
    J Comput Chem; 2013 Apr; 34(9):790-801. PubMed ID: 23280926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.